Cindy Reiss-Clark - Feb 20, 2024 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
Chief Commercial Officer
Signature
/s/ Luis Cantarero
Stock symbol
WST
Transactions as of
Feb 20, 2024
Transactions value $
$0
Form type
4
Date filed
2/22/2024, 06:40 PM
Previous filing
Aug 24, 2023
Next filing
Feb 20, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Award $0 +551 +12.72% $0.00 4.88K Feb 20, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to Buy) Award $0 +2.41K $0.00 2.41K Feb 20, 2024 Stock Options (Right to Buy) 2.41K $350.18 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2021 PSUs (PP20) award vesting net of taxes withheld.
F2 This grant vests in four equal installments beginning on February 20, 2025.